440 related articles for article (PubMed ID: 19949433)
1. Charged particles in radiation oncology.
Durante M; Loeffler JS
Nat Rev Clin Oncol; 2010 Jan; 7(1):37-43. PubMed ID: 19949433
[TBL] [Abstract][Full Text] [Related]
2. Accelerators for heavy-charged-particle radiation therapy.
Coutrakon GB
Technol Cancer Res Treat; 2007 Aug; 6(4 Suppl):49-54. PubMed ID: 17668952
[TBL] [Abstract][Full Text] [Related]
3. [Symposium: an attempt at radiation therapy using advanced techniques. 3. A characteristic and technological base of carbon beam therapy].
Sunaoka M
Nihon Hoshasen Gijutsu Gakkai Zasshi; 2005 Jul; 61(7):926-8. PubMed ID: 16075489
[No Abstract] [Full Text] [Related]
4. Modelling carcinogenesis after radiotherapy using Poisson statistics: implications for IMRT, protons and ions.
Jones B
J Radiol Prot; 2009 Jun; 29(2A):A143-57. PubMed ID: 19454805
[TBL] [Abstract][Full Text] [Related]
5. Prospects for proton-beam radiotherapy.
Nahum AE; Dearnaley DP; Steel GG
Eur J Cancer; 1994; 30A(10):1577-83. PubMed ID: 7833122
[TBL] [Abstract][Full Text] [Related]
6. Basics of particle therapy: introduction to hadrons.
Welsh JS
Am J Clin Oncol; 2008 Oct; 31(5):493-5. PubMed ID: 18838888
[TBL] [Abstract][Full Text] [Related]
7. Charged particle therapy--optimization, challenges and future directions.
Loeffler JS; Durante M
Nat Rev Clin Oncol; 2013 Jul; 10(7):411-24. PubMed ID: 23689752
[TBL] [Abstract][Full Text] [Related]
8. The National Center for Oncological Hadron Therapy: status of the project and future clinical use of the facility.
Orecchia R; Fossati P; Rossi S
Tumori; 2009; 95(2):169-76. PubMed ID: 19579862
[TBL] [Abstract][Full Text] [Related]
9. Particle beam therapy (hadrontherapy): basis for interest and clinical experience.
Orecchia R; Zurlo A; Loasses A; Krengli M; Tosi G; Zurrida S; Zucali P; Veronesi U
Eur J Cancer; 1998 Mar; 34(4):459-68. PubMed ID: 9713294
[TBL] [Abstract][Full Text] [Related]
10. New modalities in cancer treatment: heavy charged particles.
Hall EJ
Br J Radiol; 1981 Sep; 54(645):773-81. PubMed ID: 6271324
[TBL] [Abstract][Full Text] [Related]
11. Constituent components of out-of-field scatter dose for 18-MV intensity modulated radiation therapy versus 3-dimensional conformal radiation therapy: a comparison with 6-MV and implications for carcinogenesis.
Ruben JD; Smith R; Lancaster CM; Haynes M; Jones P; Panettieri V
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):645-53. PubMed ID: 25084609
[TBL] [Abstract][Full Text] [Related]
12. Radiobiology with heavy charged particles: a historical review.
Skarsgard LD
Phys Med; 1998 Jul; 14 Suppl 1():1-19. PubMed ID: 11542635
[TBL] [Abstract][Full Text] [Related]
13. High control rates of proton- and carbon-ion-beam treatment with intensity-modulated active raster scanning in 101 patients with skull base chondrosarcoma at the Heidelberg Ion Beam Therapy Center.
Mattke M; Vogt K; Bougatf N; Welzel T; Oelmann-Avendano J; Hauswald H; Jensen A; Ellerbrock M; Jäkel O; Haberer T; Herfarth K; Debus J; Uhl M
Cancer; 2018 May; 124(9):2036-2044. PubMed ID: 29469932
[TBL] [Abstract][Full Text] [Related]
14. On the cost-effectiveness of Carbon ion radiation therapy for skull base chordoma.
Jäkel O; Land B; Combs SE; Schulz-Ertner D; Debus J
Radiother Oncol; 2007 May; 83(2):133-8. PubMed ID: 17490770
[TBL] [Abstract][Full Text] [Related]
15. [Is a linac able to do better than tomotherapy or Cyberknife?].
Maingon P; Truc G; Peignaux K; Crehange G
Cancer Radiother; 2007 Nov; 11(6-7):345-8. PubMed ID: 17897857
[TBL] [Abstract][Full Text] [Related]
16. Spot scanning proton therapy for malignancies of the base of skull: treatment planning, acute toxicities, and preliminary clinical outcomes.
Grosshans DR; Zhu XR; Melancon A; Allen PK; Poenisch F; Palmer M; McAleer MF; McGovern SL; Gillin M; DeMonte F; Chang EL; Brown PD; Mahajan A
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):540-6. PubMed ID: 25304948
[TBL] [Abstract][Full Text] [Related]
17. Proposal for a program in particle-beam radiation therapy in the the United States. A report from the Committee for Radiation Oncology Studies (CROS) and its Particle Subcommittee.
Cancer Clin Trials; 1978; 1(3):153-208. PubMed ID: 117912
[TBL] [Abstract][Full Text] [Related]
18. Optimization of physical dose distributions with hadron beams: comparing photon IMRT with IMPT.
Oelfke U; Bortfeld T
Technol Cancer Res Treat; 2003 Oct; 2(5):401-12. PubMed ID: 14529305
[TBL] [Abstract][Full Text] [Related]
19. Comparing the use of protons and carbon ions for treatment.
Uhl M; Herfarth K; Debus J
Cancer J; 2014; 20(6):433-9. PubMed ID: 25415691
[TBL] [Abstract][Full Text] [Related]
20. Malignant induction probability maps for radiotherapy using X-ray and proton beams.
Timlin C; Houston M; Jones B
Br J Radiol; 2011 Dec; 84 Spec No 1(Spec Iss 1):S70-8. PubMed ID: 22374550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
